Alimanio, Jolina S.

HRN: 19-71-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
LEVOFLOXACIN 500MG (TAB)
11/04/2025
11/10/2025
PO
500mg
OD
T/c Lung Abscess
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Choice 

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: